Key Takeaways: Edible Garden’s non-perishable unit sales increased 17% year-over-year, led by shelf-stable product lines. Private label products sold through major retailers grew 19.1% in Q2 2025. International vitamin and supplements revenue rose 66.5% year-over-year. Acquisition of NaturalShrimp aquaculture facility expands R&D, IP portfolio, and production capacity. Strategic portfolio optimization continued with exits from low-margin categories and investments in higher-margin CEA-informed products. Edible Garden Q2 2025 Financial Overview Edible Garden AG Incorporated (Nasdaq: EDBL, EDBLW) reported revenue of $3.1 million for the three months ended June 30, 2025, compared with $4.3 million in Q2 2024. The decline primarily reflects the Company’s strategic exit from the floral and lettuce categories, which contributed $741,000 to the decrease. Gross profit for the quarter totaled $634,000, down from $1.56 million in the prior year period. Edible Garden attributed the decrease to changes in product mix, higher labor and raw material costs, and ongoing investment… Read More